BusinessLatest
Terns' drug may lack competitive edge
Terns' new drug is facing skepticism regarding its competitive viability in the market. Analysts suggest it may not perform as well as initially anticipated, raising concerns for investors.
0 upvotes
What happened
Terns' new drug is facing skepticism regarding its competitive viability in the market.
Why it matters
Analysts suggest it may not perform as well as initially anticipated, raising concerns for investors.